Matches in Nanopublications for { ?s ?p "[Therefore, we tested the hypothesis that ATP1A2 mutations in patients with FHM-2 are associated with hypersensitivity to NO-cGMP pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP471802.RA1UKdSLFM8jnUddOtlFtcBxxnXRxOtthlDcbrDtSirr4130_assertion description "[Therefore, we tested the hypothesis that ATP1A2 mutations in patients with FHM-2 are associated with hypersensitivity to NO-cGMP pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP471802.RA1UKdSLFM8jnUddOtlFtcBxxnXRxOtthlDcbrDtSirr4130_provenance.
- assertion description "[Therefore, we tested the hypothesis that ATP1A2 mutations in patients with FHM-2 are associated with hypersensitivity to NO-cGMP pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP256121.RAd6lD74056M-ifJETcuMoM2bRLyFwCFLicECSbPD62UM130_assertion description "[Therefore, we tested the hypothesis that ATP1A2 mutations in patients with FHM-2 are associated with hypersensitivity to NO-cGMP pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256121.RAd6lD74056M-ifJETcuMoM2bRLyFwCFLicECSbPD62UM130_provenance.
- NP656989.RAYXca-Vf1Yx7GVS9BfoKgBh4cwwvds975bUYQxIfafZI130_assertion description "[Therefore, we tested the hypothesis that ATP1A2 mutations in patients with FHM-2 are associated with hypersensitivity to NO-cGMP pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656989.RAYXca-Vf1Yx7GVS9BfoKgBh4cwwvds975bUYQxIfafZI130_provenance.